UAMY shares are roughly flat over the trailing 30 days, edging lower by about 2%, but that masks sharp intra-period swings tied to second-quarter results and a share-buyback announcement. Second-quarter revenue fell 25% year over year to $7.9 million as antimony selling prices declined about 52%, prompting management to lower its full-year 2026 revenue outlook.

Critical Metals Corp. (NASDAQ: CRML ) is an early-stage rare earth and lithium exploration company, and the central question is whether its shares can climb back toward a $10 price target from a recent price near $6.17. The strongest bullish case rests on Western demand for non-Chinese rare earth supply, the company's growing stake in Greenland's Tanbreez project, and signed off-take agreements.

EMAT fell -8.97% to $2.84 during the regular session, giving back most of the prior day's +11.83% rebound. The decline reflects profit-taking and fading "buy-the-dip" momentum after a sharp technical bounce off 52-week lows.

EMAT is trading down -11.63% at $2.68 on Monday, versus Friday’s close of $3.03, extending a premarket decline into the regular session. Q2 results were the main catalyst: revenue of $1.636M missed the $2.100M consensus, even though the -$0.02 EPS loss was narrower than the -$0.03 estimate.

IMC is down -22.43% at $7.84 during regular trading, reversing from a $10.10 prior close and a $9.80 open. The decline follows the prior session’s +26.25% surge to a 52-week high of $11.10, triggering sharp profit-taking.

UAMY fell about 16.75% over the 30-day window ended with the latest available close, from $5.97 to $4.97. The decline was driven by second-quarter 2026 results released August 11: revenue of $7.9 million, down 25% year over year and below consensus expectations.

UAMY plunged -21.73% on Wednesday, falling from a prior close of $6.58 to $5.15, with the selloff beginning in premarket trading and accelerating during the regular session. The primary catalyst was a deeply disappointing Q2 2026 earnings report released after Monday's close: revenue of $7.9M missed consensus estimates by roughly $13.8M as antimony average selling prices collapsed -52% year-over-year to $13.70 per pound.

MP is a leading U.S. rare earth producer with integrated mining and magnet manufacturing, benefiting from government price support and defense initiatives. UAMY focuses on antimony and related critical minerals, recently securing a major $245 million U.S. Defense Logistics Agency contract that has driven sharp revenue growth.

Both MP and USAR operate in the rare earth materials sector, positioning them as key players in U.S. efforts to reduce reliance on foreign supply chains for critical minerals used in electric vehicles, renewables, and defense applications. MP benefits from established production at its Mountain Pass facility, while USAR focuses on vertical integration including mining, processing, and magnet manufacturing with recent expansion moves.

USA Rare Earth (USAR) shares edged approximately 3.9% higher over the last 30 days, trading near $19.20, reflecting a modest recovery from July lows. The company is aggressively executing a mine-to-magnet vertical integration strategy, anchored by its Stillwater, Oklahoma magnet manufacturing facility and multiple high-profile acquisitions.

USAR is trading at $19.50 during Monday's regular session, up +0.88% from Friday's close of $19.33, adding to last week's +29% surge from $14.95. The primary catalyst is anticipation ahead of the company's Q2 2026 earnings release after today's market close, with analysts forecasting an EPS loss of -$0.19 on revenue of $6.45 million.

EMAT closed the previous session at 3.66 and traded down to 3.13 intraday, for a -14.48% decline during regular market hours. The move occurred amid continued selling pressure with no major company-specific news released today.

Profit surge: Underlying earnings jumped 43% year-over-year to $6.85 billion for the half year ended June 30, 2026, the highest half-year profit in four years. Revenue growth: Consolidated sales revenue rose 15% to $31.03 billion, supported by higher commodity prices and increased production volumes across key commodities.

MP Materials shares declined approximately 14% over the past 30 days, falling from $57.55 on June 12 to $49.50 as of July 13, 2026. China's decision to add MP Materials to its export-control blacklist in late June triggered a sharp selloff despite the company's limited direct exposure to Chinese supply chains.

IPX fell -8.16% during regular trading on July 8, sliding from a prior close of $25.85 to $23.74, extending losses after an -8.85% drop the previous session. The selloff was triggered by the pricing of a $50 million underwritten public offering of 2.275 million ADSs at $21.98 per ADS — a steep discount to the prevailing market price.

ALM shares fell sharply, declining approximately 20.29% from the prior session's close of $20.68 to a latest available price of $16.485. The primary catalyst was the company's announcement of an oversubscribed $700 million convertible senior notes offering, which raised dilution concerns among investors.

Shares of USAR are declining approximately 11.00% during Friday's trading session on June 5, 2026, falling from a prior close of $27.10 to an intraday low near $24.16. The primary catalyst is a sector-wide rare earth equities selloff, compounded by a "sell the news" reaction to USA Rare Earth's June 4 finalization of up to $1.6 billion in Department of Commerce CHIPS-Act funding — a landmark deal that investors had already priced in during a preceding rally.

EMAT shares fell approximately 8.70% from the prior session close of $7.99 to a latest available price of $7.295. The decline follows the company's Q1 earnings release showing a widened net loss and comes amid prior warnings about a delayed 10-Q filing and potential Nasdaq compliance risks.

Shares of SGML are declining approximately 13% on Monday, May 18, 2026, falling from a Friday, May 15 close of $16.82 to approximately $14.97 — a continuation of the earnings-driven selloff that began on May 13 and has now erased approximately 28% of SGML's value from the May 13 session open near $20.72, as the market processes a Q1 2026 earnings report that delivered record margins but also disclosed forward cost headwinds and confirmed a year-over-year revenue decline that is inconsistent with the valuation the stock had built through April and early May.

UAMY stock rose approximately +15% over the past 30 days, driven by heightened demand for antimony amid supply chain concerns and new contract announcements. Over the past quarter, the stock gained around +32%, supported by robust revenue growth reported in fiscal 2025 earnings and expansions in critical minerals operations.